Abstract:OBJECTIVE:To search the role of Helicobacter pylori (H. pylori) in the progression of gastric carcinogenesis.METHODS:A cohort study was conducted by cluster randomized sampling in Linqu County, a rural area in Shandong Province in northeast China, where the mortality of gastric cancer (GC) is among the highest in the world. In 1989-1990, a gastroscopic examination and serum test was launched among subjects aged 35-64 from 14 randomized villages. Histological diagnosis of gastric mucosa and enzyme-linked immunosorbent assay was used to detect gastric lesions and anti-H. pylori of all participants. A repeated gastroscopic screening was offered to all cohort members in 1994 and 1999 respectively, and all the GC cases, regardless of natural ones or ones by gastroscopy, were registered in the follow-up periods.RESULTS:Fifty-eight cases of GC were identified in 2469 subjects during the 10-year follow-up, 44 were observed in 1603 H. pylori-positive persons (2.74%) and 14 in 866 H. pylori-negative persons (1.62%). The incidence rate of GC in H. pylori-positive is significantly higher than in H. pylori-negative (OR = 1.871, 95% CI: 1.012 - 3.459). There was no significant difference in the progression of gastric carcinogenesis between H. pylori-positive and H. pylori-negative (P > 0.05) among subjects with normal or superficial gastritis (SG) at baseline. In contrast, the significant difference was found in baseline chronic gastritis (CAG) group (P < 0.01), and the GC incidence rate in H. pylori-positive (7/615) is higher than in H. pylori-negative (0/470, P = 0.019). The difference of gastric lesions between H. pylori-positive and H. pylori-negative in subjects with intestinal metaplasia (IM) and dysplasia (DYS) at baseline was statistically significant after a 10-year follow-up (P < 0.05, P < 0.01, respectively), but the GC incidence rate in H. pylori-positive is similar to the rate in H. pylori-negative at the two groups (17/573 and 7/224 in IM group, P = 0.907; 19/368 and 7/122 in DYS group, P = 0.806).CONCLUSIONS:H. pylori is a key risk factor that prompts the transition from chronic atrophic gastritis to advanced precancerous lesions and influences the whole progression of precancerous gastric lesions. H. pylori, perhaps can not cause GC directly, increases the risk of GC in company with other carcinogens. H. pylori seemingly has no important effect on the development of GC when gastric mucosa is normal or superficial gastritis, but this conclusion is required to be further confirmed.

Research progress of role of Helicobacter pylori on oncogenesis and progression of pancreatic cancer

Research Progress on Oncogene, Suppressor Gene andtheir Products in Gastric Carcinoma

Progress of Study on the Eradication of Helicobacter Pylori Infection and Gastric Cancer

Helicobacter pylori and Gastrointestinal Cancers: Recent Advances and Controversies

[Helicobacter Pylori and the Progression of Gastric Cancer: a 10-Year Cohort Study].

Helicobacter Pylori Infection in Cholangiocarcinoma Tissues

The Research Progress in the Relationship between H.pylori and Gastric Cancer

Helicobacter Pylori and Gastric Cancer Progression

Association Between Helicobacter Pylori Infection And Pancreatic Cancer Development: A Meta-Analysis

Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy

Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer

Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies

The Research Progress about the Role of COX-2 in the Relationship between Helicobacter Pylori and Gastric Cancer

Helicobacter Pyloriinfection and Esophageal Cancer Risk: an Updated Meta-Analysis

Pathogenic Microorganisms and Pancreatic Cancer

[Effect of Helicobacter Pylori-Encoded CagA on Biological Behavior of Gastric Adenocarcinoma Cells in Vitro].

Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies.

Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum

Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and translational perspectives

The Role of Helicobacter Pylori Infection in the Development of Gastric Cancer - Review of the Literature

Research advances in the role of gastrointestinal microbe in pancreatic cancer